ICD-10 Coding for Secondary Lung Cancer(C25.9, C34.91, C34.91U)
Explore the ICD-10 coding guidelines for secondary lung cancer, including code ranges, documentation requirements, and common pitfalls.
Complete code families applicable to Secondary Lung Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C78.00 | Secondary malignant neoplasm of unspecified lung | Use when metastasis to the lung is confirmed but laterality is not specified. |
|
| C78.01 | Secondary malignant neoplasm of right lung | Use when metastasis to the right lung is confirmed. |
|
| C78.02 | Secondary malignant neoplasm of left lung | Use when metastasis to the left lung is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSecondary Lung Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Secondary Lung Cancer.
Failing to specify laterality in documentation.
Impact
Clinical: Impacts treatment planning and monitoring., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to unspecified codes.
Mitigation
Always document laterality for lung metastases., Use templates that prompt for complete information.
Using primary lung cancer codes for metastatic disease.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data on cancer prevalence and treatment.
Mitigation
Use C78.0x codes for metastases to the lung.
Incorrect sequencing of primary and secondary codes
Impact
Leads to incorrect DRG assignment and reimbursement issues.
Mitigation
Train coders on proper sequencing rules and documentation requirements.